2022-2025 Research Funding Competition

Future SCN funded research competitions will be announced at later date.

SCN’s national research funding competition supports world-class, translational, regenerative medicine research, across the research continuum, to facilitate health, social and economic benefits for Canadians.

On September 1, the Stem Cell Network launched the second and final of two national research funding competitions planned for SCN’s 2022-2025 funding cycle. This new competition supports research activities during the 2023 to 2025 time period, and were announced publicly on May 16, 2023, and can be found here.

When combined with SCN’s Round 1 research funding competition, a total of 56 stem cell and regenerative medicine research projects and clinical trials were funded. These research projects were funded through eight programs that focus on innovation, clinical translation, policy and societal impact and commercialization.

During the 2022-2025 funding cycle SCN offered these programs:

Accelerating Clinical Translation Awards
SCN provided up to $600,000 to support multi-disciplinary research that is moving towards the clinic within five years; or is addressing a key research question associated with an ongoing clinical trial.

Clinical Trial Awards
SCN provided up to $1,000,000 to support early-stage clinical trial projects with high translational potential.

Early Career Researcher Jump Start Awards
SCN provided up to $300,000 for early career researchers (within the first five years of an initial academic appointment) to develop a research program with a regenerative medicine focus.

Fueling Biotechnology Partnerships Awards
SCN provided up to $400,000 to support academic partnerships with emerging Canadian regenerative medicine biotechnology companies to bring innovative technologies or therapies to the clinic or market.

Horizon Awards
SCN provided up to $3,000,000 to fuel national multi-disciplinary teams focused on developing transformative technology solutions for tackling significant regenerative medicine challenges.

Impact Awards
SCN provided up to $250,000 to support proof-of-principle experiments, including novel therapeutic or technical approach development that will drive regenerative medicine therapies forward.

Impact Awards: ELSI Stream 
SCN provided up to $200,000 to support the knowledge generation and/or translation of regenerative medicine research for targeted stakeholders and/or users.

Translation & Society Teams Award
SCN provided up to $750,000 to support high-calibre ELSI research teams to undertake innovative, high-impact research that facilitates regenerative medicine for the benefit of society.